Image Credit: Canva
When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.
The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.
But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.
Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.
BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.
Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.
Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.
Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.
A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."
The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.
For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.
With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.
Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).
Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.
Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.
Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.
Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.
Credit: iStock
Endometriosis is a chronic disease affecting about 1 in 10 women worldwide. Diagnosis and treatment remain challenging, particularly for women with severe pain and other complications.
Now, US researchers have developed a targeted nanotherapy that showed promising results against endometriosis in early testing.
Scientists at Washington State University found that the treatment reduced endometriosis lesions, symptoms and pain sensitivity after a single dose in mice.
The findings were published in Advanced Healthcare Materials. Researchers hope to eventually test the treatment in humans.
Also read: Endometriosis Can Take Years To Diagnose But This AI Tool Can Identify Its Signs In 18 Milliseconds
The drug, niclosamide, was previously used to treat intestinal tapeworm infections in humans and is still used in animals.
Earlier research found that niclosamide could reduce endometriosis lesions and inflammation. However, it is not suitable for long-term use, limiting its potential as a treatment for a chronic condition.
To overcome this, researchers developed a nanotherapy that delivers niclosamide directly to cells associated with endometriosis.
“We found the disease-specific immune cell, and then we had a drug, but we couldn’t target the cell with the drug alone,” said Kanako Hayashi, professor at WSU’s School of Molecular Biosciences.
“So we used this nanocarrier that delivers the drug specifically to the disease site,” Hayashi said.
The team used a nanosized molecule called a dendrimer to bind with niclosamide and deliver it in a more soluble form.
In mice, a single injection reduced the size and number of lesions and lowered pain sensitivity.
“Although we still need to clear multiple phases, this study is telling us the efficacy is strong, and this nanocarrier is stable, so far, for two weeks—and we think we can go longer,” Hayashi said.
If the treatment remains stable for longer periods, researchers believe it could potentially be given less frequently. Hayashi said a monthly injection could be possible in the future, but this would depend on further testing.
READ: Endometriosis Taught Me To Always Listen To My Body, Says Model Padma Lakshmi
Not yet. The treatment has only been tested in mice and must undergo further safety and efficacy testing before human trials.
Researchers also do not yet know whether it would ultimately be given as an injection or IV infusion.
Endometriosis affects an estimated 190 million women worldwide. It occurs when tissue similar to the lining of the uterus grows outside the uterus.
It can cause severe pelvic pain, painful periods, pain during sex and infertility. Symptoms are sometimes dismissed as a “bad period,” contributing to delays in diagnosis.
There is currently no cure, although treatments can help manage symptoms.
Treatment depends on symptoms, disease severity and fertility goals.
Hormonal medicines can help control pain and disease activity but may cause side effects and can affect fertility while being used.
Painkillers, including non-steroidal anti-inflammatory drugs, may help manage discomfort.
Laparoscopic surgery can remove lesions and endometriotic cysts and may help restore pelvic anatomy. It can also improve fertility in some women, although the disease can recur.
Lifestyle measures such as regular exercise, stress management and dietary changes may also support symptom management.
Credit: iStock
Lung development of the fetus depends on the physical and genetic health of the parents.
At birth, breathing begins with air from the environment, containing oxygen and other gases, and is influenced by known and unknown forces of nature. The air then passes through well-developed nostrils, which regulate the air temperature and prevent foreign bodies from entering the body and help protect against diseases.
Breath travels through the nasal passages, sinuses, pharynx (throat), larynx (voice box), trachea (breathing tubes), bronchi, small airways, air sacs, interstitial membrane, into thin-walled blood vessels that transport oxygen and collect gases and other substances to be expelled from the body.
The diaphragm, the muscle that separates the lungs from the abdomen, is the most powerful breathing apparatus.
The lungs in the early stages of life undergo dramatic changes from newborn→ infancy→ childhood→ puberty→ teenage→ adults→ middle age→ seniors. Factors influencing lung health risks keep changing with age, depending on genetics, environment & external factors.
The lungs and airways perform non-respiratory functions of protecting the body against harmful insults, both from within and external threats, and it also protects against insults received from other organs of the body. The lungs have a powerful defense mechanism protecting the body and also have hormonal, physical, and immunological defense mechanisms.
Credit: AI
A small lump in the neck is easy to overlook, especially when there is no pain. In many cases, it has a simple explanation, such as an infection or a swollen lymph node. Thyroid nodules are also common, and most of them are not cancerous.
The thyroid is a small gland at the front of the neck. When cancer develops in the thyroid, a lump or swelling may sometimes be the first noticeable change. It may remain painless, which is one reason people tend to wait before getting it checked.
The way a lump changes over time can provide an important clue. A swelling that suddenly becomes larger, feels harder, remains in place for several weeks deserves attention.
Other changes can include persistent hoarseness, difficulty swallowing, a feeling of pressure in the neck or, less commonly, difficulty breathing. Swollen lymph nodes on the side of the neck can also occur. These symptoms are not specific to thyroid cancer and may be related to other causes, but they should not be dismissed if they persist.
Also read: Thyroid Medicine Recall Gets US FDA’s Highest Risk Rating: What To Know
A doctor will first examine the neck and assess the size and location of the swelling. An ultrasound is often used to look more closely at the thyroid and any nodules present.
If a nodule has features that call for further investigation, a fine-needle aspiration may be advised. A small sample of cells is taken with a thin needle and examined to determine whether further treatment or monitoring is required.
A painless lump does not automatically mean cancer, and discovering a thyroid nodule is not a reason to panic. At the same time, a swelling that stays for over three weeks, grows or is accompanied by changes in swallowing or voice should be evaluated.
Early assessment can help identify whether the lump is related to the thyroid, an infection or another condition, and whether any follow-up is needed.
By Dr Akshat Malik, Senior Consultant, Head & Neck Oncology, Indraprastha Apollo Hospital, Delhi
© $2026 Times Horizon Private Limited